Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
LBRX	LB Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.20M	n/a	-8.4%	n/a	-$3.13
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
KYNB	Kyntra Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$183.45M	n/a	n/a	n/a	$45.37
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
KTTA	Pasithea Therapeutics Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.43M	n/a	-37.0%	n/a	-$2.91
KRSA	Korsana Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.07M	-$3.53M	-170.1%	-38.8%	3.7%	-$1.11
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
KROS	Keros Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$244.06M	$87.01M	35.7%	28.7%	n/m	$2.30
KPTI	Karyopharm Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$146.07M	-$196.04M	-134.2%	n/a	0.6%	-$17.93
KPRX	Kiora Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.84M	n/a	-67.2%	-100.0%	-$2.64
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
KAPA	Kairos Pharma, Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.45M	n/a	-85.9%	n/a	-$0.30
KALA	Kala Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.98M	n/a	-385.6%	n/a	-$3.31
JUNS	Jupiter Neurosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.8K	-$8.64M	n/m	n/a	n/a	-$0.25
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
JBIO	Jade Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$127.41M	n/a	-38.3%	n/a	-$3.19
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
IXHL	Incannex Healthcare Inc. Manufacturing · Year ended 2026-06-30 · USD	$0	-$19.30M	n/a	-28.6%	-100.0%	-$1.66
ISCO	International Stem Cell Corp Manufacturing · Year ended 2025-12-31 · USD	$9.10M	-$418.0K	-4.6%	n/a	0.2%	-$0.05
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
IRON	Disc Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$212.18M	n/a	-28.7%	n/a	-$6.01
IRD	Opus Genetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.20M	-$49.59M	-349.3%	-323.1%	29.1%	-$0.80
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38

Rows per page: 2550 100